Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Susan M. Geyer
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
ORCID:
0009-0002-5649-6909
Observed ORCID:
0009-0002-5649-6909
OpenAlex ID:
A5138214713
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
2026
·
Saubia Fathima
, Margaret Mei‐Kay Wong
, et al.
·
American Journal of Hematology
·
2
PA-377 Quadruplet Induction Followed by Teclistamab Consolidation and Doublet Maintenance in Patients with Primary Plasma Cell Leukemia (QUANTUM): A Prospective Randomized Phase 2 Study
2026
·
Douglas W. Sborov
, Susan M. Geyer
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma
2026
·
Sanjal H. Desai
, Susan M. Geyer
, et al.
·
Blood Cancer Journal
PDF
Show more works
View as search
Works count:
3
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
